Vitalhub Corp. (TSE:VHI) Receives Average Rating of “Buy” from Analysts

Shares of Vitalhub Corp. (TSE:VHI) have been given a consensus rating of “Buy” by the seven ratings firms that are covering the company, MarketBeat reports. Six research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is C$13.14.

Separately, National Bank Financial reduced their price objective on Vitalhub from C$14.00 to C$11.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 27th.

Vitalhub Price Performance

Shares of VHI stock opened at C$6.58 on Monday. Vitalhub has a 12 month low of C$6.46 and a 12 month high of C$14.64. The company has a market capitalization of C$416.25 million, a PE ratio of 54.83, a price-to-earnings-growth ratio of 1.18 and a beta of 0.91. The firm’s 50-day moving average is C$7.16 and its two-hundred day moving average is C$7.70.

Vitalhub (TSE:VHI) last issued its quarterly earnings data on Thursday, May 7th. The company reported C$0.04 earnings per share (EPS) for the quarter. The firm had revenue of C$31.91 million for the quarter. Vitalhub had a net margin of 6.13% and a return on equity of 2.98%. Sell-side analysts forecast that Vitalhub will post 0.2296467 EPS for the current year.

About Vitalhub

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.